Citizens JMP raised the firm’s price target on Evolent Health (EVH) to $13 from $12 and keeps an Outperform rating on the shares. Evolent’s Q4 ...

Healthcare solutions company Evolent Health (NYSE:EVH) in Q4 CY2024, but sales rose 16.3% year on year to $646.5 million.

Evolent Health Inc (NYSE:EVH) is set to release its Q4 2024 earnings on Feb 20, 2025. The consensus estimate for Q4 2024 ...

Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting earnings tomorrow afternoon. Here’s what investors should ...

Welcome to the Evolent earnings conference call for the fourth quarter and year ended December 31, 2024. All participants ...

Shares of NYSE EVH opened at $10.44 on Friday. Evolent Health has a 1-year low of $9.45 and a 1-year high of $35.00. The company has a 50-day moving average of $10.75 and a two-hundred day moving ...

NYSE EVH opened at $10.44 on Friday. Evolent Health has a one year low of $9.45 and a one year high of $35.00. The stock has a 50-day moving average of $10.75 and a 200 day moving average of $18. ...

Reports Q4 revenue $646.5M, consensus $650.9M. Seth Blackley, Co-Founder and Chief Executive Officer of Evolent stated, “Evolent delivered ...

CEO Seth Blackley noted Evolent Health achieved $2.55 billion in revenue for 2024, reflecting a 30% growth over the prior year, and $160.5 million in adjusted EBITDA at the low end of the guidance ...

Evolent Health (EVH) came out with a quarterly loss of $0.02 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.23 per share a year ago. These figures are ...

Full Year 2024 Results Key Financial Results Revenue: US$2.55b (up 30% from FY 2023).

Evolent Health, Inc. ( NYSE: EVH) Q4 2024 Earnings Conference Call February 20, 2025 5:00 PM ET Seth Frank - Vice President, Investor Relations Seth Blackley - Chief Executive Officer John Johnson - ...